EP1313523A1 — Inhalation device
Assigned to Glaxo Group Ltd · Expires 2003-05-28 · 23y expired
What this patent protects
According to the present invention there is provided an inhalation device for dispensing medicament comprising a body ( 150 ), the body being shaped for receipt of a medicament carrier ( 286 ); and an actuator ( 10 ) having a mouthpiece ( 20 ), the actuator being reversibly movab…
USPTO Abstract
According to the present invention there is provided an inhalation device for dispensing medicament comprising a body ( 150 ), the body being shaped for receipt of a medicament carrier ( 286 ); and an actuator ( 10 ) having a mouthpiece ( 20 ), the actuator being reversibly movable between a dispensing position and a storage position; wherein the body includes an air channel ( 253 ), and the actuator includes an air hole ( 225 ) such that the air channel communicates with the air hole when the actuator is in the dispensing position and the air channel and air hole do not communicate when the actuator is in the storage position.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.